Through EpiPen4Schools™ Program, Mylan Helps Schools Better Prepare For Students With Life-Threatening Allergies BASKING RIDGE, N.J., Aug. 14, 2012 /PRNewswire/ -- Mylan Specialty L.P., the fully-integrated specialty pharmaceutical...
Mylan N.V.(NASDAQ, TASE: MYL) today announced its EpiPen4Schools® program has surpassed the one millionth epinephrine auto-injector donation through the program and that presented data at the American College of Allergy, Asthma and Immunology (ACAAI) 2017 Annual Scientific Meeting demonstrates the impact of and continued need for the program in U.S. schools. Epinephrine auto-injectors provided through the program have been used more than 2,000 times to treat anaphylaxis, a potentially life-threa
When you block a person, they can no longer invite you to a private message or post to your profile wall. Replies and comments they make will be collapsed/hidden by default. Finally, you'll never receive email notifications about content they create or likes they designate for your content.
Note: if you proceed, you will no longer be following .